D-Index & Metrics Best Publications

Yves Vanrenterghem

KU Leuven
Belgium

Medicine

Belgium

2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 92 Citations 28,264 509 World Ranking 7071 National Ranking 78

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Belgium Leader Award

Best Publications

Reduced exposure to calcineurin inhibitors in renal transplantation.

Henrik Ekberg;Helio Tedesco-Silva;Alper Demirbas;Štefan Vítko.
The New England Journal of Medicine (2007)

1919 Citations

PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION

J Grinyo;C Groth;R Pichlmayr;Sa Sadek.
The Lancet (1995)

1553 Citations

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

F. Vincenti;B. Charpentier;Y. Vanrenterghem;L. Rostaing.
American Journal of Transplantation (2010)

891 Citations

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

T van Gelder;L B Hilbrands;Yves Vanrenterghem;W Weimar.
Transplantation (1998)

753 Citations

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients

Bert Bammens;Pieter Evenepoel;H Keuleers;Kristin Verbeke.
Kidney International (2006)

498 Citations

The pharmacokinetic‐pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

Michael D. Hale;Andrew J. Nicholls;Roy E.S. Bullingham;Ronald Hené.
Clinical Pharmacology & Therapeutics (1998)

485 Citations

Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients.

Sabina De Geest;Liesbeth Borgermans;Hilde Gemoets;Ivo Abraham;Ivo Abraham.
Transplantation (1995)

455 Citations

Prevalence and management of anemia in renal transplant recipients: a European survey

Yves Vanrenterghem;Claudio Ponticelli;José Maria Morales;Daniel Abramowicz.
American Journal of Transplantation (2003)

394 Citations

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.

Barry D. Kahan;Bruce A. Julian;Mark D. Pescovitz;Yves Vanrenterghem.
Transplantation (1999)

392 Citations

Free p-cresol is associated with cardiovascular disease in hemodialysis patients

B.K.I. Meijers;B. Bammens;B. De Moor;K. Verbeke.
Kidney International (2008)

369 Citations

If you think any of the details on this page are incorrect, let us know.

Yves Vanrenterghem

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Research.com Recognitions

Awards & Achievements

Best Publications

Report an issue

Frequent Co-Authors

Best Scientists Citing Yves Vanrenterghem

Trending Scientists